CORAL GABLES, FL / ACCESSWIRE / November 9, 2015 / There's no secret that small cap stocks can be some of the most volatile. Catalysts such as market momentum, news, or even social buzz can quickly spark high powered runs. This year the biotech sector has seen this first hand. From medical devices to new drug therapies, speculators and earnings forecasters have reacted to announcements as well as industry rumors with resulting action in the market finding, at time, aggressive bull runs. Companies like BioElectronics Corporation (PINKSHEETS: BIEL), Aeterna Zentaris Inc. (NASDAQ: AEZS), and AgriEuro Corp. (OTCQB: EURI) have seen increases in share price and volume over the last few weeks.
In fact, just this morning, BioElectronics Corporation made an announcement. The maker of advanced consumer pain management medical devices, today announced that it has received an initial order for its ActiPatch(R) Musculoskeletal Pain Relief products from Superdrug pharmacies. This pharmacy chain is a subsidiary of the world's largest international health and beauty retailer, A.S. Watson Group, with 12,000 stores. In a previous update from October, company chairman Richard Staelin stated, "We are poised to move out of the development stage with this company and fulfill its potential as we change the way people heal and successfully manage their chronic pain."
"Superdrug will promote BioElectronics 7-Day Trial Device, to create product demand on their web site," said Ben Fichter, Marketing Director, BioElectronics Corporation. "We are looking forward to collaborating with this innovative retailer to extend our successful marketing program into the retail environment."
Since hitting lows in mid September of $0.0003, the stock has rebounded by as much as 733% following highs of $0.0025 earlier in October. As of Friday's close, shares of BIOL remained 267% above those previous lows with the stock closing at $0.0011.
Aeterna Zentaris Inc. reported its financial and operating results as at and for the third quarter ended September 30, 2015, last week. David A. Dodd, Chairman, President and Chief Executive Officer of the Company, stated, "Despite our continued progress in transforming the Company, the price of our common shares remained under intense pressure during the third quarter as a result of the exercise of Series B Common Share Purchase Warrants ("Series B Warrants"). At the beginning of the quarter, 26,812,308 Series B Warrants were outstanding. We finished the quarter with 6,880,170. As a result of the agreements we reached with the major holders of the Series B Warrants on November 1, only approximately 0.8 million Series B Warrants will remain outstanding, representing approximately 2.7% of the number originally issued. While the dilution caused by the Series B Warrants is substantially ended, we find it necessary to ask our fellow shareholders to approve another share consolidation. We believe that a share consolidation will permit our common shares to remain listed on The Nasdaq Capital Market, which will permit us to raise capital again on reasonable terms, further supporting our focus on developing a profitable, growth-oriented pharmaceutical business."
Since October 30 the stock has moved up in price by as much as 78% following highs on November 4th of $0.0725.
AgriEuro has also regained ground following lows in late October of $0.201. Since then the stock has climbed as high as $0.615. This morning the company announced that the company plans to use its tanks for the farming of Pike, Crucian, Carp and Bream which will all thrive in this environment. "The company will efficiently utilize its 25 km dam, tanks and canals to maximize production. I expect that we'll continue finding new ways of monetizing this property as we get further into the development stages" Radu Cosmin Monda, CEO of AgriEuro Corp. Pre market activity in the stock has seen over 100,000 shares traded before the market open and at prices between $0.3999 and $0.535.
ABOUT US:
www.DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. You can subscribe to the www.DailyStockReporter.com newsletter and start receiving daily alerts. To subscribe by phone and receive messages directly to a mobile phone, text the phrase "StockAlerts" to 63566.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
EGM FIRM INC which owns www.DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.
EGM FIRM INC, which owns www.DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice.
EGM FIRM INC which owns www.DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
CONTACT:
Company: DailyStockReporter.com
Contact Email: news@dailystockreporter.com
SOURCE: DailyStockReporter.com
